Cardiovascular imaging in clinical practice: what does late gadolinium enhance?
- PMID: 23462791
- PMCID: PMC4382352
- DOI: 10.1001/jama.2013.1806
Cardiovascular imaging in clinical practice: what does late gadolinium enhance?
Conflict of interest statement
Comment on
-
Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.JAMA. 2013 Mar 6;309(9):896-908. doi: 10.1001/jama.2013.1363. JAMA. 2013. PMID: 23462786
-
Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease.JAMA. 2013 Mar 6;309(9):909-18. doi: 10.1001/jama.2013.1381. JAMA. 2013. PMID: 23462787 Free PMC article.
References
-
- Fraser AG, Buser PT, Bax JJ, et al. The future of cardiovascular imaging and non-invasive diagnosis: a joint statement from the European Association of Echocardiography, the Working Groups on Cardiovascular Magnetic Resonance, Computers in Cardiology, and Nuclear Cardiology, of the European Society of Cardiology, the European Association of Nuclear Medicine, and the Association for European Paediatric Cardiology. Eur Heart J. 2006;27(14):1750–1753. - PubMed
-
- Gulati A, Jabbour A, Ismail TF, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013;309(9):896–908. - PubMed
-
- Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100(19):1992–2002. - PubMed
-
- McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108(1):54–59. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
